Liquidia Technologies (LQDA) Price & Analysis

Compare

637 Followers

LQDA Stock Chart & Stats

Day’s Range― - ―

52-Week Range$8.75 - $28.00

Previous CloseN/A

Volume97.81K

Average Volume (3M)2.99M

Market Cap

$2.39B

Enterprise Value$1.05B

Total Cash (Recent Filing)$173.42M

Total Debt (Recent Filing)$50.91M

Price to Earnings (P/E)―

Beta1.73

Next Earnings

Nov 11, 2025

EPS Estimate

-0.41

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.49

Shares Outstanding86,091,450

10 Day Avg. Volume3,755,322

30 Day Avg. Volume2,987,146

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.44

Enterprise Value/Revenue54.30

Enterprise Value/Gross Profit77.18

Enterprise Value/Ebitda-8.48

Forecast

1Y Price Target

$35.91

Price Target Upside29.50% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering11

Bulls Say, Bears Say

Bulls Say

EarningsAnalyst raised the price target to $49 from $40 after pulling forward near-term YUTREPIA revenue projections to reflect the current cadence of uptake.

Market AdoptionThe initial pace of adoption and updated ASCENT trial results reflect Yutrepia's differentiated profile.

Product LaunchYutrepia's early launch is solid with over 550 patients on treatment and more than 900 prescriptions.

Bears Say

Investor SentimentShort interest is notably high at 30.5% of the float, which could indicate skepticism or bearish sentiment among some investors.

Patent LitigationLiquidia Technologies faces two major overhangs: a 5-year patent battle with UTHR and competition from INSM’s once-daily inhaled treprostinil.

Liquidia Technologies News

Liquidia Technologies put volume heavy and directionally bearish

Bearish flow noted in Liquidia (LQDA) Technologies with 4,771 puts trading, or 1.3x expected. Most active are Oct-25...

2d ago

LQDA

Liquidia Technologies put volume heavy and directionally bearish

Bearish flow noted in Liquidia (LQDA) Technologies with 5,592 puts trading, or 1.8x expected. Most active are Nov-25...

3d ago

LQDA

Liquidia assumed with a Buy at Jefferies

Jefferies assumed coverage of Liquidia (LQDA) with a Buy rating and a price target of $43, up from...

13d ago

LQDA

UTHR

Liquidia price target raised to $35 from $23 at BofA

BofA raised the firm’s price target on Liquidia (LQDA) to $35 from $23 and keeps a Buy rating...

15d ago

LQDA

Liquidia price target raised to $31 from $25 at Wells Fargo

Wells Fargo raised the firm’s price target on Liquidia (LQDA) to $31 from $25 and keeps an Overweight...

16d ago

LQDA

Liquidia reports Q2 EPS (49c), consensus (39c)

Reports Q2 revenue $8.84M, consensus $3.89M. Cash and cash equivalents totaled $173.4M as of June 30, vs. $176.5M...

16d ago

LQDA

United Therapeutics up 7%, Liquidia down 9% in afternoon trading

Shares of United Therapeutics (UTHR) and Liquidia (LQDA) are moving sharply in opposite directions in Friday afternoon trading....

27d ago

LQDA

UTHR

Bleecker Street Research short United Therapeutics, long Liquidia

Funds managed by Bleecker Street are short United Therapeutics and long Liquidia. In a recently published report titled...

30d ago

LQDA

UTHR

Promising Growth and Market Differentiation for Liquidia Technologies: Buy Rating with $43 Price Target

Amy Li, an analyst from Jefferies, has initiated a new Buy rating on Liquidia Technologies (LQDA). Amy Li’s...

13d ago

LQDA

Strong Initial Performance and Strategic Market Entry of Liquidia Technologies’ Yutrepia Drives Buy Rating

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Liquidia Technologies. The associated price target...

15d ago

LQDA

Liquidia Corporation’s Strong Launch of YUTREPIA

Liquidia Technologies ( ($LQDA) ) has released its Q2 earnings. Here is a breakdown of the information Liquidia...

15d ago

LQDA

Promising Outlook for Liquidia Technologies: Strong Start for Yutrepia Drives Buy Rating

Analyst Serge Belanger from Needham maintained a Buy rating on Liquidia Technologies and increased the price target to...

16d ago

LQDA

Promising Market Launch and Growth Potential for Liquidia Technologies’ Yutrepia

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Liquidia Technologies, boosting the price target...

16d ago

LQDA

LQDA Earnings this Week: How Will it Perform?

Liquidia Technologies (LQDA) is scheduled to report 2nd quarter earnings on 08/12/2025, before the market opens. Regarding Q2...

18d ago

LQDA

LQDA FAQ

What was Liquidia Technologies’s price range in the past 12 months?

Liquidia Technologies lowest stock price was $8.75 and its highest was $28.00 in the past 12 months.

What is Liquidia Technologies’s market cap?

Liquidia Technologies’s market cap is $2.39B.

When is Liquidia Technologies’s upcoming earnings report date?

Liquidia Technologies’s upcoming earnings report date is Nov 11, 2025 which is in 75 days.

How were Liquidia Technologies’s earnings last quarter?

Liquidia Technologies released its earnings results on Aug 12, 2025. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.432 by -$0.058.

Is Liquidia Technologies overvalued?

According to Wall Street analysts Liquidia Technologies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Liquidia Technologies pay dividends?

Liquidia Technologies does not currently pay dividends.

What is Liquidia Technologies’s EPS estimate?

Liquidia Technologies’s EPS estimate is -0.41.

How many shares outstanding does Liquidia Technologies have?

Liquidia Technologies has 86,091,450 shares outstanding.

What happened to Liquidia Technologies’s price movement after its last earnings report?

Liquidia Technologies reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.432. Following the earnings report the stock price went up 13.679%.

Which hedge fund is a major shareholder of Liquidia Technologies?

Currently, no hedge funds are holding shares in LQDA

Liquidia Technologies Stock Smart Score

Outperform

Fundamentals

Return on Equity

-363.16%

Trailing 12-Months

Asset Growth

45.13%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Liquidia Technologies (LQDA) Earnings & Revenues

Historic Earnings Reports

LQDA Company Deck

LQDA Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected a strong start for YUTREPIA, with impressive prescription numbers and conversion rates, positive study results, and a solid financial position. However, challenges with market entry blocks and reliance on channel inventory for initial revenue were noted.View all LQDA earnings summaries

LQDA Stock 12 Month Forecast

Average Price Target

$35.91

▲(29.50% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","30":"$30","55":"$55","17.5":"$17.5","42.5":"$42.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$54.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,17.5,30,42.5,55],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.68,20.473846153846154,23.267692307692307,26.06153846153846,28.855384615384615,31.64923076923077,34.44307692307692,37.23692307692308,40.03076923076923,42.824615384615385,45.61846153846154,48.41230769230769,51.206153846153846,{"y":54,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.68,19.08230769230769,20.484615384615385,21.886923076923075,23.28923076923077,24.69153846153846,26.09384615384615,27.496153846153845,28.898461538461536,30.300769230769227,31.70307692307692,33.10538461538461,34.5076923076923,{"y":35.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.68,16.78153846153846,15.883076923076922,14.984615384615385,14.086153846153845,13.187692307692307,12.28923076923077,11.39076923076923,10.492307692307692,9.593846153846155,8.695384615384615,7.796923076923077,6.8984615384615395,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.04,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.59,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.22,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.98,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.23,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.23,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.49,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.51,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.98,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.68,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >